Highlights from MDS and Nonmalignant Hematology - New drugs for MDS: Rigosertib, Luspatercept, Ibrutnib - 100459

Spotlight
Video

Highlights from MDS and Nonmalignant Hematology - New drugs for MDS: Rigosertib, Luspatercept, Ibrutnib

moasc has 295 videos Subscribe Here

Loading........
Description: Kanwarpal Kahlon, MD, from Ronald Reagan UCLA Medical Center talks about the highlights from Myelodysplastic Syndrome (MDS) and nonmalignant hematology and also new drugs for MDS: Rigosertib, Luspatercept, Ibrutnib at MOASC’s Spotlight On® Hematology in Huntington Beach.
Shared By : moasc
Posted on : 02/01/18
Added : 3 months ago